Pharma Blog Watch

Pediatric Allegra Approved (The Pharm Voice)
In her blog, Gloria Gamat reports that sanofi-aventis has received FDA approval for its liquid formulation of Allegra "for the twice-daily treatment of symptoms associated with seasonal allergies in pediatric patients, 2 to 11 years of age, and for the treatment of chronic idiopathic urticaria in children 6 months to 11 years of age."